About this trial
Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing techniques and technologies that allow more extensive, safe resections.
This study will test a loupe-based wearable device in the clinical setting and compare its accuracy with a large operative microscope to identify tumor tissues. Postoperative histopathological analysis on tumor tissues will be used as gold standards for comparison. The outcome from this study will be a low-cost, miniaturized, easy-to-operate, loupe-based fluorescence imaging device for intraoperative guidance of brain tumor resection with the same level of accuracy as the large microscope.
Eligibility criteria
Qualifiers
adults with brain malignant gliomas undergoing resection
at least 18 years of age
able to understand the consent
Disqualifiers
pregnant women
under 18 years of age
patients undergoing emergency surgery
inability to give consent due to dysphagia or language barrier
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Guoqiang Yu
Lead sponsor
University of Kentucky
Sponsor institution
Bioptics Technology LLC
Collaborator
National Cancer Institute (NCI)
Collaborator
Kentucky Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
Collaborator